Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Becton, Dickinson and Company
  6. News
  7. Summary
    BDX   US0758871091

BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Delayed Nyse  -  04:00 2022-08-12 pm EDT
263.69 USD   +1.65%
08/12INSIDER SELL : Becton Dickinson & Co.
MT
08/12INSIDER SELL : Becton Dickinson & Co.
MT
08/09BECTON DICKINSON & CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Becton, Dickinson and Company Recalls Intraosseous Products

06/23/2022 | 03:29am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about BECTON, DICKINSON AND COMPANY
08/12INSIDER SELL : Becton Dickinson & Co.
MT
08/12INSIDER SELL : Becton Dickinson & Co.
MT
08/09BECTON DICKINSON & CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/09Becton, Dickinson and Company, Labcorp Collaborate to Develop Flow Cytometry-Based Comp..
CI
08/08BECTON DICKINSON AND : Announces Tender Offers for Outstanding Debt Securities - Form 8-K
PU
08/08BECTON DICKINSON & CO : Other Events (form 8-K)
AQ
08/08BD Announces Tender Offers for Outstanding Debt Securities
PR
08/08BECTON, DICKINSON AND COMPANY : SEC Filing 8K
CO
08/04BECTON DICKINSON & CO Management's Discussion and Analysis of Financial Condition and ..
AQ
08/04SECTOR UPDATE : Health Care Stocks Mixed Pre-Bell Thursday
MT
More news
Analyst Recommendations on BECTON, DICKINSON AND COMPANY
More recommendations
Financials (USD)
Sales 2022 18 845 M - -
Net income 2022 1 866 M - -
Net Debt 2022 13 567 M - -
P/E ratio 2022 38,6x
Yield 2022 1,44%
Capitalization 75 203 M 75 203 M -
EV / Sales 2022 4,71x
EV / Sales 2023 4,50x
Nbr of Employees 75 000
Free-Float 77,6%
Chart BECTON, DICKINSON AND COMPANY
Duration : Period :
Becton, Dickinson and Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BECTON, DICKINSON AND COMPANY
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Last Close Price 263,69 $
Average target price 274,67 $
Spread / Average Target 4,16%
EPS Revisions
Managers and Directors
Thomas E. Polen Chairman, President & Chief Executive Officer
Christopher J. DelOrefice Chief Financial Officer & Executive Vice President
William R. Sigmund Chief Medical Officer & Executive Vice President
Elizabeth McCombs Senior Vice President-Research & Development
Joseph M. Smith Chief Scientific Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
BECTON, DICKINSON AND COMPANY7.29%75 203
ABBOTT LABORATORIES-20.79%195 226
MEDTRONIC PLC-8.34%125 988
HOYA CORPORATION-14.17%39 624
SARTORIUS STEDIM BIOTECH-20.96%36 037
DEXCOM, INC.-33.08%35 266